Peptides and muscle research: what studies actually look at (2026)

BPC-157, TB-500, CJC-1295, ipamorelin, IGF-1 LR3, MOTS-c: three peptide families come up in every discussion. Here is what laboratories study, what the studies measure, what they do not, and what the World Anti-Doping Agency says.

Reading time: 5 min

The short answer

Preclinical research looks at three families: tissue repair peptides (BPC-157, TB-500), GH / IGF-1 axis peptides (CJC-1295, ipamorelin, sermorelin, GHRP-2, tesamorelin, IGF-1 LR3) and mitochondrial metabolism peptides (MOTS-c, SS-31). Published data come mostly from cell cultures and animal models. None of it proves an effect in humans. And every one of these molecules except SS-31 falls under the 2026 WADA list.

Three families, three research questions

Each family answers a different laboratory question. The linked guides detail mechanisms and publications; the product pages give the reference, the format and the available certificate.

GH / IGF-1 axis

How does the pituitary release GH, and what does IGF-1 do downstream?

Two signalling routes. GHRH analogues (CJC-1295, sermorelin, tesamorelin) bind the GHRH receptor; secretagogues (ipamorelin, GHRP-2) bind the ghrelin receptor. Studies measure pulsatile GH release, then circulating IGF-1. IGF-1 LR3, a long half-life analogue, is used to study the IGF-1 receptor directly on cultured muscle cells.

Product pages

Guides

Mitochondrial metabolism

How does a muscle cell produce and manage its energy?

MOTS-c is a peptide encoded by the mitochondria's own DNA: it activates AMPK, the cell's energy sensor. SS-31 (elamipretide) binds cardiolipin, a lipid of the inner mitochondrial membrane. In cells and in aged mice, teams measure mitochondrial respiration, oxidative stress and the expression of metabolic genes.

Product pages

Guides

What studies measure, and what they do not

What they measure

Markers: binding to a receptor, a circulating hormone level, gene expression, cell migration in a culture dish, the look of a tissue under the microscope in animals.

What they do not measure

A gain in mass or strength in humans. Published human trials on these molecules are rare, small, or focused on a specific medical indication unrelated to training.

Why the gap matters

A mouse is not a human, a cell is not an organism. A marker that moves in the lab says nothing about an outcome in a person. That is why we promise nothing, and why nobody should.

Anti-doping status: what the 2026 WADA list says

The World Anti-Doping Agency publishes its Prohibited List every year. The 2026 list has been in force since 1 January 2026. Every class below is prohibited at all times, in and out of competition, along with substances of similar structure or effect.

MoleculeSection of the list
BPC-157S0 · Non-approved substances (named)
TB-500S2.3 · Growth factors (named)
IGF-1 LR3S2.3 · Growth factors (“IGF-1 and its analogues”)
CJC-1295S2.2.4 · GH releasing factors (named)
SermorelinS2.2.4 · GH releasing factors (named)
TesamorelinS2.2.4 · GH releasing factors (named)
IpamorelinS2.2.4 · GH releasing factors (named)
GHRP-2S2.2.4 · GH releasing factors (named)
MOTS-cS4.4.1 · Metabolic modulators (named)
SS-31Not named on the 2026 list

Anyone subject to anti-doping testing checks each substance with their national agency or on the WADA website. This table does not replace the official list.

Choosing a reagent: four checks before you order

  1. A verifiable report

    A task number and a key, verifiable on the laboratory's website. Without them, a PDF is just a picture.

  2. The right payer

    The report's "Client" field must carry the seller's name. A report ordered by someone else speaks about someone else's stock.

  3. Purity and content

    Purity by HPLC, identity by mass spectrometry, and the actual vial content in mg, not just a percentage.

  4. The same reference

    Same molecule, same format as the product page. A 5 mg report says nothing about a 10 mg vial.

On these references, a product page without a report in our name shows none. We say it as it is.

Frequently asked questions

Which peptides does research study around muscle tissue?

Three families: tissue repair (BPC-157, TB-500), the GH / IGF-1 axis (CJC-1295, ipamorelin, sermorelin, GHRP-2, tesamorelin, IGF-1 LR3) and mitochondrial metabolism (MOTS-c, SS-31). The data come mostly from cell cultures and animal models.

Do these peptides build muscle?

Nobody can claim that, and we do not. Published studies measure markers, in animals or in cells; they demonstrate no gain in humans. Our reagents are sold for in vitro research only.

Is BPC-157 banned by WADA?

Yes. The 2026 WADA list names it in section S0, non-approved substances, prohibited at all times. TB-500, IGF-1 and its analogues, CJC-1295, ipamorelin, sermorelin, tesamorelin, GHRP-2 and MOTS-c are listed too, in sections S2 and S4.

How do I recognise a reliable reagent?

A verifiable analysis report (task number + key), ordered by the seller itself, giving purity by HPLC, identity by mass spectrometry and the actual vial content, for the same reference as the product page.

Are these peptides intended for human use?

No. They are reagents sold exclusively for laboratory research (RUO), not for human or veterinary use.

Compare the product pages. Check the reports. Order.